Table 2.
Intervention group | Control group | Estimate*(95% CI) | p value | |
---|---|---|---|---|
Primary outcome† | 21; 58·4% (21·6) | 21; 40·5% (23·8) | 20·1% (5·2–35·0) | 0·011 |
Primary outcome adjusted‡ | 21; 58·4% (21·6) | 21; 40·5% (23·8) | 14·5% (0·9–28·2) | 0·038 |
Primary outcome adjusted with additional covariates§ | 21; 58·4% (21·6) | 21; 40·5% (23·8) | 18·5% (1·4–35·6) | 0·036 |
Data are N; mean (SD), unless otherwise specified. N is the number of pharmacies. Outcome is the percentage of effective contraception uptake at 4 months follow-up.
The estimated treatment effect (percentage difference between groups) in proportion with the outcome.
Adjusted for phase, treatment group, and centre.
Adjusted for phase, treatment group, centre, mean age, percentage of participants in a current sexual relationship, and percentage of participants who had used effective contraception previously.
Post-hoc analysis adjusted in addition to the prespecified baseline covariates for ethnicity and having given birth previously.